EGR2 and glioblastoma: Specifically, temozolomide treatment restricted cell invasion, migration, and angiogenesis but facilitated cell autophagy and apoptosis in glioblastoma via the inactivation of the LINC00470/EGR2/SOX4 axis (Figure 6).